Biopharmaceuticals

关注
Illustration of Amazonian scorpion venom research showing potential against breast cancer, with lab equipment and scientists.
AI 生成的图像

Amazonian scorpion venom peptide shows paclitaxel-like action against breast cancer cells in lab tests

由 AI 报道 AI 生成的图像 事实核查

Researchers in Brazil have identified a molecule in the venom of the Amazonian scorpion Brotheas amazonicus that kills breast cancer cells in vitro with effects similar to the chemotherapy drug paclitaxel, according to FAPESP. Early tests indicate the peptide chiefly induces necrosis, underscoring venoms’ promise as a source of biopharmaceuticals.

此网站使用 cookie

我们使用 cookie 进行分析以改进我们的网站。阅读我们的 隐私政策 以获取更多信息。
拒绝